In the first half of 2022, our teams advised on 80 mergers, acquisitions, venture capital financings and other transactions in the Life Sciences sector. Highlights include advising:
Showcasing our litigation strengths in the life sciences sector, last month, an Orrick appellate team engineered the reversal of a $120 million judgment for Johnson & Johnson in talc litigation. (The team had previously helped reduce the original verdict from $325 million to $120 million). American Lawyer recognized our team as “Litigators of the Week” for the win, which is the second major reversal we’ve secured in the J&J talc litigation in the last 18 months. These decisions not only wiped-out massive judgments, but established precedent supporting J&J’s central legal position in hundreds of similar cases pending across the country.